Factors Influencing Placebo Responses in Rheumatoid Arthritis Clinical Trials: A Meta-Analysis of Randomized, Double-Blind, Placebo-Controlled Studies Kota NagaiKeisuke MatsubayashiKoji Kawakami Systematic Review 17 January 2020 Pages: 197 - 209
Systemic Treatment for Metastatic Hormone Sensitive Prostate Cancer: A Comprehensive Meta-Analysis Evaluating Efficacy and Safety in Specific Sub-Groups of Patients Vincenzo Di NunnoMatteo SantoniFrancesco Massari Systematic Review 28 January 2020 Pages: 211 - 226
Practical Considerations for Treatment of Relapsed/Refractory FLT3-ITD Acute Myeloid Leukaemia with Quizartinib: Illustrative Case Reports David Martínez-CuadrónGabriela Rodríguez-MacíasPau Montesinos Practical Application Open access 07 January 2020 Pages: 227 - 235
Food Effect on a Single High Dose of Carotegrast Methyl, an Oral Antagonist of α4-Integrin, in Healthy Male Subjects: A Randomised, Placebo-Controlled, Double-Blind Study Hiroyuki FukaseToshifumi KajiokaHidetoshi Furuie Original Research Article Open access 22 January 2020 Pages: 237 - 247
Comparison of the Efficacy and Safety of Pregabalin and Duloxetine in Taxane-Induced Sensory Neuropathy: A Randomized Controlled Trial Ebrahim SalehifarGhasem JanbabaeiRazieh Avan Original Research Article 10 January 2020 Pages: 249 - 257
Clinical Pharmacokinetics, Safety and Exploratory Efficacy Study of a Topical Bactericidal VB-1953: Analysis of Single and Multiple Doses in a Phase I Trial in Acne Vulgaris Subjects Shilpi JainVishal YadavNeal Bhatia Original Research Article 11 January 2020 Pages: 259 - 268
Comparison of the Effects of Secukinumab and Adalimumab Biosimilar on Radiographic Progression in Patients with Ankylosing Spondylitis: Design of a Randomized, Phase IIIb Study (SURPASS) Xenofon BaraliakosMikkel Østergaardthe SURPASS Study Group Original Research Article 25 January 2020 Pages: 269 - 278
Correlations Among Subcutaneous Immunoglobulin Dosage, Immunoglobulin G Serum Pre-infusional Levels and Body Mass Index in Primary Antibody Deficiency Patients: A Pooled Analysis from the SHIFT/IBIS Studies Antonio PecoraroSilvia RicciFor the SHIFT and IBIS Study Groups Short Communication Open access 08 February 2020 Pages: 279 - 286
Comment On: “Stratifying Therapeutic Enoxaparin Dose in Morbidly Obese Patients by BMI Class: A Retrospective Cohort Study” Nameer van OosteromKarl WinckelMichael Barras Letter to the Editor 03 February 2020 Pages: 287 - 288
Response to Comment on: “Stratifying Therapeutic Enoxaparin Dose in Morbidly Obese Patients by BMI Class: A Retrospective Cohort Study” Young R. Lee Letter to the Editor 03 February 2020 Pages: 289 - 290
Correction to: Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: Their Use and Differential Features Katherine A. Lyseng-Williamson Correction Open access 10 February 2020 Pages: 291 - 291
